Health Care
Viking Therapeutics earnings preview: All eyes on NASH
Viking Therapeutics (VKTX) is scheduled to report fourth-quarter 2018 financial results on March 13, Wednesday, after the regular trading hours.…
Earnings Preview Q4: Cara Therapeutics’ success in 2019 will depend on Korsuva trial outcomes
Cara Therapeutics (CARA) is scheduled to report its fourth quarter and full-year 2018 financial results on Tuesday, March 12, after…
Tilray rides on successful cannabis harvest in Europe
Tilray’s (TLRY) stock made strong gains early Wednesday after the Canadian marijuana giant said its European arm had a very…
Aurora Cannabis dethrones Canopy Growth as Cowen’s top pot stock
Research firm Cowen on Tuesday named Aurora Cannabis (ACB) its top stock pick for the marijuana industry, replacing Canopy Growth…
La Jolla Pharma stock declines after reporting Q4 earnings results
La Jolla Pharmaceutical Company (LJPC) reported its Q4 and full-year 2018 results after the market closed today. The company reported…
Biogen buys Nightstar, eyeing a bigger pie in ophthalmic gene therapy
Continuing the efforts to diversify into new areas of drug development, Biogen (BIIB) this week clinched an important deal that…
Portola Pharmaceuticals rises on strong Q4 earnings
Shares of Portola Pharmaceuticals (PTLA) gained 5.6% during pre-market trading on Friday, after the company posted a loss of $1.04…
Earnings: Dentsply Sirona Q4 profit beats despite revenue drop; stock jumps
Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth…
Celgene stock takes a dive after major Bristol-Myers stakeholder opposes merger deal
It's was a wild day for big pharma after Celgene Corp (CELG) slid at least 8% on early Thursday trade…
Trending stocks: Tandem Diabetes, Weight Watchers, MercadoLibre and more
TOP GAINERS Tandem Diabetes Care (TNDM) on Tuesday said its COO John Sheridan will take over as the CEO of…